{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:39:41Z","timestamp":1781840381528,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jaad.2013.05.028","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T04:02:48Z","timestamp":1373515368000},"page":"565-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent"],"prefix":"10.1016","volume":"69","author":[{"given":"Jane","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.05.028_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archderm.134.12.1509","article-title":"The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum","volume":"134","author":"Nousari","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09546630310016826","article-title":"Mycophenolate in dermatology","volume":"14","author":"Liu","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2013.05.028_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.05.028_bib4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria","volume":"43","author":"Su","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1610-0387.2005.05022.x","article-title":"Pyoderma gangrenosum","volume":"3","author":"Conrad","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2013.05.028_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00000637-200101000-00005","article-title":"A rationale for adjuvant surgical intervention in pyoderma gangrenosum","volume":"46","author":"Kaddoura","year":"2001","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2013.05.028_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1046\/j.1524-4725.2000.0260111063.x","article-title":"Surgical management of pyoderma gangrenosum: case report and review","volume":"26","author":"Alam","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2013.05.028_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archdermatol.2009.57","article-title":"Mycophenolate mofetil as therapy for pyoderma gangrenosum","volume":"145","author":"Eaton","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09546630410020154","article-title":"Mycophenolate mofetil in pyoderma gangrenosum","volume":"15","author":"Lee","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2013.05.028_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2133.2001.04036.x","article-title":"Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis","volume":"144","author":"Gilmour","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1468-3083.2000.00019.x","article-title":"Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix","volume":"14","author":"Wollina","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.05.028_bib13","first-page":"173","article-title":"Pyoderma gangrenosum: a review of 86 patients","volume":"55","author":"Powell","year":"1985","journal-title":"Q J Med"},{"key":"10.1016\/j.jaad.2013.05.028_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2013.05.028_bib15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1365-2133.2007.08212.x","article-title":"Adalimumab for treatment of pyoderma gangrenosum","volume":"157","author":"Pomerantz","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.143.3.306","article-title":"Adalimumab treatment for pyoderma gangrenosum","volume":"143","author":"Heffernan","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.05.028_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: etiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2013.05.028_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/TP.0b013e318205568c","article-title":"Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study","volume":"91","author":"Langone","year":"2011","journal-title":"Transplantation"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221300594X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221300594X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:26:58Z","timestamp":1759271218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221300594X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S019096221300594X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.05.028","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}